TAPI is the leading international supplier of active pharmaceutical ingredients (APIs). With the industry’s broadest portfolio of over 300 API products, TAPI achieved third-party sales of some $692 million in 2013. A standalone unit within Teva Pharmaceutical Industries, TAPI’s history in the generic API industry dates back over 75 years. Headquartered in Israel, next to Tel Aviv, TAPI employs more than 5,000 professionals at over 20 sites worldwide. TAPI’s state-of-the-art production facilities are located in Italy, Hungary, the Czech Republic, Croatia, Israel, India, China, Mexico, Puerto Rico and the United States.
TAPI provides superior product quality, excellent customer service and unparalleled IP assets that protect your freedom. Our significant ongoing investment in R&D generates a steady flow of APIs, enabling timely introduction of new products to market. The large R&D group comprises over 750 world-class scientists located in seven development centers. Our dedicated professionals specialize in the fields of chemical synthesis, fermentation, high potency APIs, plant extraction, synthetic peptides, vitamin D derivatives, prostaglandins, and analytical and solid-state R&D. Read more about TAPI’s API expertise and value-added services.